Espen Thiis-Evensen

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 10

Top Topics

Mesenchymal Stem Cells

Neoadjuvant Chemotherapy

Top Venues

World journal of surgery

Journal of neuroendocrinology

This page only lists publications with an associated author ORCID identifier.

Publications

Dimitrios Papantoniou, Katarzyna Fröss-Baron, Ulrike Garske-Román, Anders Sundin, Espen Thiis-Evensen, Malin Grönberg, Staffan Welin, Eva Tiensuu Janson
Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients. Journal of neuroendocrinology (2024)
Katarina Edfeldt, Per Hellman, Dan Granberg, Pernilla Lagergren, Espen Thiis-Evensen, Anders Sundin, Camilla Andersson
Improved health-related quality of life during peptide receptor radionuclide therapy in patients with neuroendocrine tumours. Journal of neuroendocrinology (2023)
Espen Thiis-Evensen, Raziye Boyar Cetinkaya
Incidence and prevalence of neuroendocrine neoplasms in Norway 1993-2021. Journal of neuroendocrinology (2023)
Espen Thiis-Evensen
Letter to the Editor: Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation. World journal of surgery (2022)
Espen Thiis-Evensen
Letter to the Editor: Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation. World journal of surgery 47 (4) (2022)
Espen Thiis-Evensen
Letter to the Editor: Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation. World journal of surgery 47 (4) (2022)
Espen Thiis-Evensen
Letter to the Editor: Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation. World journal of surgery 47 (4) (2022)
Espen Thiis-Evensen, Amalie Christine Poole, Hong-Thien Thi Nguyen, Jon Sponheim
Achieving objective response in treatment of non-resectable neuroendocrine tumors does not predict longer time to progression compared to achieving stable disease. BMC cancer 20 (1) (2020)
Achyut Ram Vyakaranam, Joakim Crona, Olov Norlén, Dan Granberg, Ulrike Garske-Román, Mattias Sandström, Katarzyna Fröss-Baron, Espen Thiis-Evensen, Per Hellman, Anders Sundin
Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with 177Lu-DOTATATE. Cancers 11 (7) (2019)
Terje Løitegård, Dag T Berntzen, Espen Thiis-Evensen
The RECIST criteria compared to conventional response evaluation after peptide receptor radionuclide therapy in patients with neuroendocrine neoplasms. Annals of nuclear medicine 33 (3) (2018)